Tirzepatide is FDA approved. Getting it is still confusing.
You can get tirzepatide four different ways in 2026, and the price gap between the cheapest and most expensive route is roughly 5x. The branded version (Mounjaro for diabetes, Zepbound for obesity) lists for over $1,000 a month. Compounded tirzepatide through a telehealth clinic runs $249 to $399. Eli Lilly's own self-pay platform, LillyDirect, sits in the middle. And peptide vials are the cheapest path of all, with the most friction. Here's how each route actually works in 2026, what it costs, and who should pick which one.
Real GLP-1 before and after results
Four real before-and-after photos from users online who shared their GLP-1 results. Identifiers blurred for privacy. Click any photo to expand.
Photos sourced from users online who publicly shared their GLP-1 results. All four used compounded semaglutide or tirzepatide, the same medications available through MEDVi and Yucca Health telehealth. Individual results vary; trial average is 15-20% body weight loss at 60+ weeks.
🔑 Key Takeaways
- LillyDirect Self Pay is the cheapest branded option at $349 to $549/mo for vials, no prescription needed for the consultation, ships in 5 to 7 days.
- Telehealth compounded tirzepatide ($249 to $399/mo) is the most popular route in 2026, with full physician oversight and same molecule as Mounjaro/Zepbound.
- Insurance covers Zepbound for obesity if your BMI qualifies and your plan includes it. Most do not.
- Peptide vials are the cheapest path ($150 to $250/mo equivalent) but require self-administration knowledge and offer no medical oversight.
- If you've stalled on tirzepatide and want more potency, retatrutide is the triple agonist that hit 24.2% weight loss in Phase 2 vs tirzepatide's 22.5%.
Here's how each path actually works.
Route 1: LillyDirect Self Pay (the manufacturer's direct channel)
This is Eli Lilly's own direct-to-consumer platform. It launched in 2024 and now offers Zepbound vials at flat self-pay pricing without going through traditional pharmacy retail markup.
How it works: Visit LillyDirect.com, complete a telehealth consultation with a partner provider (FORM Health or LifeMD), and if approved, vials ship to your door from Lilly's pharmacy network in about 5 to 7 days.
Pricing as of 2026:
- Zepbound 2.5mg vial (4-week starter): $349
- Zepbound 5mg vial: $499
- Zepbound 7.5mg, 10mg, 12.5mg, 15mg vials: $549 to $599
Best for: People who want the brand-name, FDA-approved product without dealing with insurance or pharmacy retail prices, and who don't qualify for compounded options.
Tradeoff: Vials require self-administration with a separate syringe (no autoinjector pen at this price). The 2.5mg starter vial gives you 4 weeks but you need to titrate up, and each higher dose gets a fresh vial price.
Route 2: Telehealth Compounded Tirzepatide
This is the most-used route in 2026. Compounded tirzepatide is the same active molecule as Mounjaro and Zepbound, prepared by a 503A or 503B compounding pharmacy under physician prescription.
Status note: The FDA officially declared the tirzepatide shortage resolved in late 2024, which means 503B outsourcing facilities can no longer mass-produce compounded tirzepatide in the same way. However, 503A pharmacies can still compound personalized formulations under individual prescriptions, and many telehealth platforms work through this channel.
How it works: Sign up with a telehealth platform (Henry Meds, Mochi Health, Eden, Sequence/WeightWatchers Clinic, or similar), complete an intake form and labs, get prescribed if eligible (BMI 27+ with comorbidity, or 30+ for general weight loss), and the compounding pharmacy ships your monthly supply.
Pricing in 2026: $249 to $399 per month all-in (consultation + medication). Most platforms bundle the cost.
Best for: The largest patient cohort. Full physician oversight, prescription paper trail, pharmacy-grade preparation, and roughly half the cost of branded Zepbound.
Tradeoff: Compounded availability has tightened post-shortage. Some platforms have started adding B12 or L-carnitine to the formulation to keep it legally compliant as a "personalized" preparation. Whether those additives matter clinically is debatable.
Route 3: Insurance + In-Person Prescription
If your insurance covers Zepbound or Mounjaro, this is the cheapest legitimate route by far. Most plans don't cover obesity medications, but more are adding coverage in 2026 as employer demand grows.
How it works: Talk to your primary care doctor or an obesity medicine specialist. They prescribe Zepbound (for weight loss) or Mounjaro (for type 2 diabetes). You fill at your regular pharmacy.
Pricing:
- Insurance copay (if covered): $25 to $100/month
- Eli Lilly Mounjaro Savings Card: $25/month for eligible commercial-insurance patients with diabetes
- Zepbound Savings Card: $25 with commercial insurance, or up to $463 off without
- Cash retail without coverage: $1,060/month for Zepbound, similar for Mounjaro
Best for: Anyone with insurance that covers obesity medications or type 2 diabetes treatment. The savings cards stack with insurance and bring real costs to under $50/month for many patients.
Tradeoff: Coverage is unpredictable. Many employers exclude weight-loss medications. Prior authorization can take 2 to 6 weeks. Step therapy (try semaglutide first) is increasingly common.
Route 4: Peptide Vials (Independent Synthesis Vendors)
This is the unregulated grey-market route. Tirzepatide is sold as a peptide compound by independent synthesis vendors, primarily in 30mg, 60mg, and 100mg vials. You reconstitute with bacteriostatic water and self-administer.
How it works: Order from a peptide vendor with a verifiable Certificate of Analysis (HPLC purity at 99%+, mass spec confirming molecular weight, batch-matched). Vials ship in 2 to 5 days from US warehouses.
Pricing in 2026:
- 30mg tirzepatide vial: $80 to $130 (about $2.67 to $4.33/mg)
- 60mg vial: $140 to $220 ($2.33 to $3.67/mg)
- 100mg vial: $180 to $300 ($1.80 to $3.00/mg)
- Effective monthly cost at 10mg/week maintenance: roughly $150 to $250 all-in including supplies
Best for: Cost-driven buyers who already understand peptide reconstitution, dose calculation, and self-injection. Same molecule as branded Zepbound at one-fourth the price.
Tradeoff: No medical oversight, no pharmacy quality assurance, no recourse if a vial is bad. Vendor quality varies dramatically. Anything under $1.50/mg from an anonymous storefront is almost certainly fake or contaminated.
Route comparison table
| Route | Monthly cost | Time to first dose | Oversight | Quality |
|---|---|---|---|---|
| Insurance copay (Zepbound/Mounjaro) | $25 to $100 | 1 to 6 weeks | Full physician + insurance gatekeeping | Pharmaceutical grade |
| Telehealth compounded | $249 to $399 | 5 to 10 days | Full physician via telehealth | Pharmacy compounded |
| LillyDirect Self Pay | $349 to $599 | 5 to 7 days | Telehealth physician | Brand-name from manufacturer |
| Cash retail (no insurance) | $1,060+ | 1 to 3 days | Standard prescription | Brand-name pharmaceutical |
| Research peptide vials | $150 to $250 | 2 to 5 days | None | Variable, vendor-dependent |
Stalled on tirzepatide? Retatrutide is the next step
Tirzepatide is a dual GLP-1 + GIP agonist. Retatrutide adds a third pathway (glucagon receptor agonism) and hit 24.2% body weight reduction in Phase 2 trials, vs tirzepatide's 22.5% in Phase 3. The Ascension R-30 vial gives you 7+ weeks of supply at maintenance dosing for around $200 total, no prescription. For people who've plateaued on tirzepatide or want maximum potency, this is the upgrade path. See our retatrutide for sale guide for the full vendor breakdown.
Which route should you actually pick?
Here's the decision tree most people land in:
- If your insurance covers Zepbound or Mounjaro and you can tolerate prior auth, go that route. You'll pay $25 to $100/month for pharmaceutical-grade product.
- If insurance doesn't cover it and you want full physician oversight, telehealth compounded ($249 to $399) is the standard 2026 path.
- If you want the brand-name product without insurance hassle, LillyDirect Self Pay ($349 to $599) is the cleanest direct-from-manufacturer route.
- If you've already done a tirzepatide cycle through telehealth and know your tolerance, research vials cut your cost by 60 to 70% if you're confident with reconstitution.
- If you've stalled on tirzepatide, the next step up is retatrutide vials. Same delivery format, more potency.
How to verify a tirzepatide source before paying
Whatever route you pick, three checks are the minimum:
- For telehealth platforms: Verify the prescribing physician is licensed in your state. Verify the compounding pharmacy is 503A or 503B accredited (PCAB or SafeCompounding.org listed). Avoid platforms that prescribe without any blood work.
- For peptide vials: Demand a batch-specific Certificate of Analysis with HPLC at 99%+, mass spec confirming the molecular weight (~4,813 Da), and an endotoxin pass. The third-party lab should be a real name (Janoshik, TrustPointe, Kovera, BioRegen).
- For LillyDirect: The platform itself is legit (run by Eli Lilly directly), but verify the partner physician network before booking. FORM Health and LifeMD are the current contracted providers.
For deeper sourcing context across the GLP-1 category, see our best legit peptide vendors guide and the where to buy tirzepatide and PT-141 page.
Frequently asked questions
Medical disclaimer. This article is for general information only. Talk to a licensed medical provider before starting any peptide protocol, especially if you are pregnant, breastfeeding, taking other medications, or managing a chronic condition.